2021 – Page 37 – Retraction Watch

Columbia grad student faked data in study of socioeconomics and life experiences, says retraction notice

Personality and Social Psychology Bulletin has retracted a 2018 paper because, according to a retraction notice, the first author changed data in a way that “resulted in incorrect and misleading results.”

The article, “Cardiovascular and self-regulatory consequences of SES-based social identity threat,” claims to show that socioeconomic status-based “social identity threat can go from ‘in the air’ to ‘under the skin’ to influence physiological and self-regulatory processes.” It has been cited twice in addition to the retraction notice, according to Clarivate Analytics’ Web of Science.

Here’s the retraction notice:

“This retraction is one of the fastest I ever experienced after reporting a paper to a journal editor.”

A researcher who has had more than 40 papers questioned by scientific sleuths has lost a second to retraction.

On December 14, Elisabeth Bik reported problems in 39 papers coauthored by Hua Tang, of Tianjin Medical University in China, to the editors of the journals that had published the papers. PubPeer commenters found problems in several other papers, and Bik tallied the 45 articles in a December 18 post.

In May, Tang lost a paper from PLOS ONE that Bik had flagged for the journal all the way back in 2015 — a delay that is not unusual for the journal, but becoming less common.

But the response this time was swift, at least for one journal. DNA and Cell Biology, a Mary Ann Liebert title, retracted “microRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells” this week. (The exact date of the retraction is unclear, as Bik notes below.)

Here’s the notice:

JAMA journal retracts its first paper, on exercise and heart disease

The authors of a 2019 meta-analysis in a JAMA journal on exercise and heart disease have retracted the paper after discovering that a quarter of the studies they’d used in the analysis did not belong.

The retraction is the first for the journal, which had published some 2,800 articles before having to pull one, Frederick P. Rivara, the editor in chief, told Retraction Watch. One in 2,800, we should note, is quite close to the 4 in 10,000 rate of retraction in the overall literature.

The study, from a group at the Universities of Manchester and Brighton, in the United Kingdom, was titled “Accelerometer- and pedometer-based physical activity interventions among adults with cardiometabolic conditions: a systematic review and meta-analysis,” and appeared in JAMA Network Open.

The authors, led by Alexander Hodkinson, looked at 36 randomized clinical trials and found that:

PLOS ONE retracts paper purporting to be about lung ultrasound for COVID-19 but that had suspicious overlap with pre-pandemic article

PLOS ONE has retracted a paper on pneumonia in people with Covid-19 after the authors could not allay concerns about the integrity of their data.

The article, “Lung ultrasound score in establishing the timing of intubation in COVID-19 interstitial pneumonia: A preliminary retrospective observational study,” appeared in September and was written by a group from Zhejiang University School of Medicine, in Hangzhou, China.

About three months after publication, PLOS ONE issued an expression of concern about the article, citing suspicious overlap with a 2018 paper in a different journal. It concluded:

Researcher linked to author with 52 retractions loses a paper for duplication

An engineering researcher alleged to be part of a four-group ring of authors who have “repetitively published their own work in ways that call into serious question” the validity of hundreds of papers has had a paper retracted.

As we reported in August, Mostafa Jalal, a postdoc at Texas A&M, is alleged to have “engaged in some manner of collaboration or communication” with three other researchers, including Ali Nazari, who has now had 52 papers retracted. Those retractions came after the whistleblower, the pseudonymous Artemisia Stricta, called attention to problems in Nazari’s work.

The newly retracted paper, originally published in 2013 in Science and Engineering of Composite Materials, is one of five publications in which Artemisia Stricta said Jalal’s group had misrepresented electron microscopy images.

Here’s the retraction notice for “Assessment of nano-TiO2 and class F fly ash effects on flexural fracture and microstructure of binary blended concrete”:

Journal becomes “victim of an organized rogue editor network”

We’re not accustomed to seeing journal article titles that end in exclamation points. But that’s what a title did earlier this month: “The Journal of Nanoparticle Research victim of an organized rogue editor network!”

The journal, a Springer Nature title, wrote the editors, “has been attacked in a new way by a sophisticated and organized network.” (It turns out not to be entirely new, but more on that in a moment.) As the editors explain:

Weekend reads: The backstory of a Nature retraction; an author salutes her favorite review of 2020; vaping-COVID-19 link questioned

Welcome to the first Weekend Reads of 2021. Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Medical writer loses COVID-19-cancer paper for plagiarism
Psychology paper retracted after creators of tool allege “serious breach of copyright”
Psychology journal retracts two articles for being “unethical, scientifically flawed, and based on racist ideas and agenda”
List of retracted COVID-19 papers grows past 70
A look back at retraction news in 2020 — and ahead to 2021

Our list of retracted or withdrawn COVID-19 papers is up to 72.

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: